20 articles
NHLBI researchers optimize collection and storage of umbilical cord blood from sickle cell-affected and healthy newborns for future stem cell therapies.
A landmark effort to bank immune-compatible stem cells matched to the majority of the US population — now terminated.
International assessment exposes inconsistencies in iPSC testing that could impact regenerative medicine safety and efficacy.
Study evaluates umbilical cord and placental tissues for cost-effective mesenchymal stem cell banking and regenerative medicine applications.
NIDCR researchers compared stromal cells from bone marrow, skin, spleen, and fat to identify which best regenerates bone and supports blood formation.
Scientists explore safer alternatives to stem cell transplants using cellular secretions that may offer similar benefits.
Researchers developed a breakthrough technique to cryopreserve cardiac endothelial cells with 95% viability for regenerative medicine.
New research exposes key obstacles researchers face when choosing pluripotent stem cells for regenerative medicine applications.
Interrupted cooling protocols boost cell viability in cryopreservation by optimizing freeze-thaw timing and temperature control.
Researchers developed a method to rejuvenate aging stem cells, extending their lifespan beyond 100 days while preserving function.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Breakthrough chemical reprogramming method transforms ordinary blood cells into versatile stem cells without genetic modification.
Revolutionary 3D culture system dramatically improves stem cell gene therapy outcomes, enhancing cell survival and therapeutic potential.
International society creates comprehensive roadmap to translate pluripotent stem cell research into approved medicines worldwide.
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
Two decades of induced pluripotent stem cell research have revolutionized regenerative medicine and opened new pathways for rejuvenation therapies.
Scientists develop guidelines to ensure stem cell studies include diverse populations, making results more applicable to everyone.
Scientists created modified stem cells that home to bone marrow, delivering targeted immune therapies while avoiding tumors entirely.
Dive deep into partial reprogramming, niche remodeling, senolytics, and cutting-edge clinical therapies — the molecular toolkit for reversing stem cell aging.
Breakthrough stem cell platform creates scalable, genetically enhanced immune cells that could revolutionize cancer treatment.
